Advertisement
No access
Report

Translational Repression and eIF4A2 Activity Are Critical for MicroRNA-Mediated Gene Regulation

Science
5 Apr 2013
Vol 340, Issue 6128
pp. 82-85

MicroRNA Mechanism

MicroRNAs are small noncoding RNAs that regulate gene expression by binding complementary target messenger RNAs (mRNAs) and repressing their expression through repression of protein translation and mRNA degradation. Meijer et al. (p. 82) show that in a HeLa cell system mRNA degradation is a consequence of translational inhibition via the initiation factor eIF4A2.

Abstract

MicroRNAs (miRNAs) control gene expression through both translational repression and degradation of target messenger RNAs (mRNAs). However, the interplay between these processes and the precise molecular mechanisms involved remain unclear. Here, we show that translational inhibition is the primary event required for mRNA degradation. Translational inhibition depends on miRNAs impairing the function of the eIF4F initiation complex. We define the RNA helicase eIF4A2 as the key factor of eIF4F through which miRNAs function. We uncover a correlation between the presence of miRNA target sites in the 3′ untranslated region (3′UTR) of mRNAs and secondary structure in the 5′UTR and show that mRNAs with unstructured 5′UTRs are refractory to miRNA repression. These data support a linear model for miRNA-mediated gene regulation in which translational repression via eIF4A2 is required first, followed by mRNA destabilization.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

Summary

Materials and Methods
Supplementary Text
Figs. S1 to S6
References (2138)

Resources

File (meijer-sm.pdf)

References and Notes

1
Jackson R. J., Hellen C. U., Pestova T. V., The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell Biol. 11, 113 (2010).
2
Fabian M. R., et al., Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. Mol. Cell 35, 868 (2009).
3
Djuranovic S., Nahvi A., Green R., miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 336, 237 (2012).
4
Bazzini A. A., Lee M. T., Giraldez A. J., Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish. Science 336, 233 (2012).
5
Béthune J., Artus-Revel C. G., Filipowicz W., Kinetic analysis reveals successive steps leading to miRNA-mediated silencing in mammalian cells. EMBO Rep. 13, 716 (2012).
6
Moretti F., Kaiser C., Zdanowicz-Specht A., Hentze M. W., PABP and the poly(A) tail augment microRNA repression by facilitated miRISC binding. Nat. Struct. Mol. Biol. 19, 603 (2012).
7
Mishima Y., et al., Translational inhibition by deadenylation-independent mechanisms is central to microRNA-mediated silencing in zebrafish. Proc. Natl. Acad. Sci. U.S.A. 109, 1104 (2012).
8
Wu L., Fan J., Belasco J. G., MicroRNAs direct rapid deadenylation of mRNA. Proc. Natl. Acad. Sci. U.S.A. 103, 4034 (2006).
9
Pillai R. S., et al., Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 309, 1573 (2005).
10
Thermann R., Hentze M. W., Drosophila miR2 induces pseudo-polysomes and inhibits translation initiation. Nature 447, 875 (2007).
11
Mathonnet G., et al., MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 317, 1764 (2007).
12
Zdanowicz A., et al., Drosophila miR2 primarily targets the m7GpppN cap structure for translational repression. Mol. Cell 35, 881 (2009).
13
Pestova T. V., Kolupaeva V. G., The roles of individual eukaryotic translation initiation factors in ribosomal scanning and initiation codon selection. Genes Dev. 16, 2906 (2002).
14
Boyerinas B., et al., Identification of let-7-regulated oncofetal genes. Cancer Res. 68, 2587 (2008).
15
Galicia-Vázquez G., Cencic R., Robert F., Agenor A. Q., Pelletier J., A cellular response linking eIF4AI activity to eIF4AII transcription. RNA 18, 1373 (2012).
16
Chekulaeva M., et al., miRNA repression involves GW182-mediated recruitment of CCR4-NOT through conserved W-containing motifs. Nat. Struct. Mol. Biol. 18, 1218 (2011).
17
Braun J. E., Huntzinger E., Fauser M., Izaurralde E., GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets. Mol. Cell 44, 120 (2011).
18
Fabian M. R., et al., miRNA-mediated deadenylation is orchestrated by GW182 through two conserved motifs that interact with CCR4-NOT. Nat. Struct. Mol. Biol. 18, 1211 (2011).
19
Cooke A., Prigge A., Wickens M., Translational repression by deadenylases. J. Biol. Chem. 285, 28506 (2010).
20
Petit A. P., et al., The structural basis for the interaction between the CAF1 nuclease and the NOT1 scaffold of the human CCR4-NOT deadenylase complex. Nucleic Acids Res. 40, 11058 (2012).
21
Kong Y. W., et al., The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene. Proc. Natl. Acad. Sci. U.S.A. 105, 8866 (2008).
22
Ricci E. P., et al., Activation of a microRNA response in trans reveals a new role for poly(A) in translational repression. Nucleic Acids Res. 39, 5215 (2011).
23
Humphreys D. T., Westman B. J., Martin D. I., Preiss T., MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc. Natl. Acad. Sci. U.S.A. 102, 16961 (2005).
24
Clark A. T., Robertson M. E., Conn G. L., Belsham G. J., Conserved nucleotides within the J domain of the encephalomyocarditis virus internal ribosome entry site are required for activity and for interaction with eIF4G. J. Virol. 77, 12441 (2003).
25
Kolupaeva V. G., Pestova T. V., Hellen C. U., Ribosomal binding to the internal ribosomal entry site of classical swine fever virus. RNA 6, 1791 (2000).
26
Totaro A., et al., The human Pat1b protein: A novel mRNA deadenylation factor identified by a new immunoprecipitation technique. Nucleic Acids Res. 39, 635 (2011).
27
di Penta A., et al., Dendritic LSm1/CBP80-mRNPs mark the early steps of transport commitment and translational control. J. Cell Biol. 184, 423 (2009).
28
Charlesworth A., Cox L. L., MacNicol A. M., Cytoplasmic polyadenylation element (CPE)- and CPE-binding protein (CPEB)-independent mechanisms regulate early class maternal mRNA translational activation in Xenopus oocytes. J. Biol. Chem. 279, 17650 (2004).
29
Pruitt K. D., Tatusova T., Brown G. R., Maglott D. R., NCBI Reference Sequences (RefSeq): Current status, new features and genome annotation policy. Nucleic Acids Res. 40, D130 (2012).
30
Benson D. A., Karsch-Mizrachi I., Lipman D. J., Ostell J., Sayers E. W., GenBank. Nucleic Acids Res. 39, D32 (2011).
31
Chatterjee S., Pal J. K., Role of 5′- and 3′-untranslated regions of mRNAs in human diseases. Biol. Cell 101, 251 (2009).
32
Friedman R. C., Farh K. K., Burge C. B., Bartel D. P., Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92 (2009).
33
Garcia D. M., et al., Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat. Struct. Mol. Biol. 18, 1139 (2011).
34
Zuker M., Stiegler P., Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res. 9, 133 (1981).
35
Gruber A. R., Lorenz R., Bernhart S. H., Neuböck R., Hofacker I. L., The Vienna RNA websuite. Nucleic Acids Res. 36, (Web Server issue), W70 (2008).
36
Petersen C. P., Bordeleau M. E., Pelletier J., Sharp P. A., Short RNAs repress translation after initiation in mammalian cells. Mol. Cell 21, 533 (2006).
37
Lewis B. P., Shih I. H., Jones-Rhoades M. W., Bartel D. P., Burge C. B., Prediction of mammalian microRNA targets. Cell 115, 787 (2003).
38
Mayr C., Hemann M. T., Bartel D. P., Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315, 1576 (2007).

(0)eLetters

eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.

Log In to Submit a Response

No eLetters have been published for this article yet.

Information & Authors

Information

Published In

Science
Volume 340 | Issue 6128
5 April 2013

Submission history

Received: 8 October 2012
Accepted: 31 January 2013
Published in print: 5 April 2013

Permissions

Request permissions for this article.

Acknowledgments

We thank E. Smith, M. Stoneley, T. Pöyry, E. Jan, C. Jopling, T. Achsel, M. Hentze, and J. Pelletier for helpful comments and reagents. This work was funded by the MRC, UK. M.B. is an MRC Senior Fellow, and A.E.W. is a Biotechnology and Biological Sciences Research Council Professorial Fellow.

Authors

Affiliations

H. A. Meijer*
Medical Research Council (MRC) Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK.
Y. W. Kong*
Medical Research Council (MRC) Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK.
W. T. Lu*
Medical Research Council (MRC) Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK.
A. Wilczynska*
Medical Research Council (MRC) Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK.
R. V. Spriggs
Medical Research Council (MRC) Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK.
S. W. Robinson
Medical Research Council (MRC) Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK.
J. D. Godfrey
Medical Research Council (MRC) Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK.
A. E. Willis
Medical Research Council (MRC) Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK.
Medical Research Council (MRC) Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK.

Notes

*
These authors contributed equally to this work.
Corresponding author. E-mail: [email protected]

Metrics & Citations

Metrics

Article Usage

Altmetrics

Citations

Cite as

Export citation

Select the format you want to export the citation of this publication.

Cited by

  1. An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron, Science Translational Medicine, 8, 347, (347ra94-347ra94), (2021)./doi/10.1126/scitranslmed.aaf5660
    Abstract
  2. Breakers and blockers—miRNAs at work, Science, 349, 6246, (380-382), (2015)./doi/10.1126/science.1260969
    Abstract
Loading...

View Options

Check Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.

More options

Register for free to read this article

As a service to the community, this article is available for free. Login or register for free to read this article.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View options

PDF format

Download this article as a PDF file

Download PDF

Full Text

FULL TEXT

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media